SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-288562
Filing Date
2020-11-09
Accepted
2020-11-09 08:26:02
Documents
15
Period of Report
2020-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d695053d8k.htm   iXBRL 8-K 42894
2 EX-10.1 d695053dex101.htm EX-10.1 172210
3 EX-99.1 d695053dex991.htm EX-99.1 13950
7 GRAPHIC g695053g1109093551230.jpg GRAPHIC 3812
  Complete submission text file 0001193125-20-288562.txt   414311

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fixx-20201109.xsd EX-101.SCH 3096
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20201109_lab.xml EX-101.LAB 18122
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20201109_pre.xml EX-101.PRE 11422
8 EXTRACTED XBRL INSTANCE DOCUMENT d695053d8k_htm.xml XML 3350
Mailing Address ONE PATRIOTS PARK BEDFORD MA 01730
Business Address ONE PATRIOTS PARK BEDFORD MA 01730 781-301-7277
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 201296233
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences